Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Adalimumab

Epstein-Barr virus associated lymphoproliferative disorders in an elderly patient: case report

    • 13 Accesses

    This is a preview of subscription content, log in to check access.

    REFERENCE

    1. 1.

      Ikeda T, Toyama S, Ogasawara M, Amano H, Takasaki Y, Morita H, Ishizuka T.Rheumatoid arthritis complicated with immunodeficiency-associated lymphoproliferative disorders during treatment with adalimumab. Modern rheumatology / the Japan Rheumatism Association 22: 458-462, No. 3, Jun 2012. Available from: URL: http://dx.doi.org/10.1007/s10165-011-0501-0 - Japan

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Adalimumab. React. Wkly. 1421, 5 (2012). https://doi.org/10.2165/00128415-201214210-00016

    Download citation

    Keywords

    • Rheumatoid Arthritis
    • Adalimumab
    • Procalcitonin
    • Lymphoproliferative Disorder
    • Left Axilla